Nano-X Imaging (NASDAQ:NNOX) Price Target Raised to $12.00 at Cantor Fitzgerald

Nano-X Imaging (NASDAQ:NNOX - Free Report) had its price objective upped by Cantor Fitzgerald from $11.00 to $12.00 in a research note released on Friday,Benzinga reports. The brokerage currently has an overweight rating on the stock.

Nano-X Imaging Price Performance

Shares of NASDAQ NNOX traded up $1.73 during midday trading on Friday, hitting $7.97. The stock had a trading volume of 16,959,342 shares, compared to its average volume of 1,585,114. Nano-X Imaging has a fifty-two week low of $5.26 and a fifty-two week high of $14.28. The company's 50-day simple moving average is $6.11 and its 200 day simple moving average is $6.89. The firm has a market cap of $460.51 million, a P/E ratio of -9.38 and a beta of 2.02.

Hedge Funds Weigh In On Nano-X Imaging

Large investors have recently modified their holdings of the company. Griffin Asset Management Inc. increased its holdings in Nano-X Imaging by 0.7% during the 2nd quarter. Griffin Asset Management Inc. now owns 203,911 shares of the company's stock worth $1,497,000 after purchasing an additional 1,500 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Nano-X Imaging by 13.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 13,716 shares of the company's stock worth $135,000 after buying an additional 1,612 shares in the last quarter. The Manufacturers Life Insurance Company raised its position in Nano-X Imaging by 14.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,210 shares of the company's stock valued at $148,000 after buying an additional 2,600 shares during the last quarter. Van ECK Associates Corp boosted its holdings in Nano-X Imaging by 14.1% during the 2nd quarter. Van ECK Associates Corp now owns 22,293 shares of the company's stock worth $164,000 after acquiring an additional 2,755 shares during the last quarter. Finally, Rhumbline Advisers grew its stake in shares of Nano-X Imaging by 3.9% in the 2nd quarter. Rhumbline Advisers now owns 75,920 shares of the company's stock worth $557,000 after acquiring an additional 2,818 shares in the last quarter. 21.49% of the stock is currently owned by institutional investors.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.